By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Genomic Vision today granted Quest Diagnostics exclusive rights to develop and offer clinical and research-use laboratory testing services for its molecular combing technique in the US, India, and Mexico.
Registering provides access to this and other free content.
Already have an account?Login Now.
The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.
In Science this week: measles virus nucleocapsid structure, and more.
African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.
Nature has retracted a 2002 epigenetics paper for image manipulation.
This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.